In a world where everyone starts off as “the norm”, when it comes to prescribing drugs, and then experiences the inevitable “suck it and see” effect, pharmacogenetics can identify more readily and accurately which direction to go in when looking for a more “effective” regime.
In an effort to clarify the mechanism behind rTMS and how much it relies on brain plasticity, Alynka identifies a dastardly dichotomy – how do you build the good connections without bringing the bad along with you…
Genetic “profiling” to optimise medication choice (Pharmacogenomics) has historically been priced out of the mainstream. Sean explains why this SYNERGIES programme could radically alter that situation…
In the previous episode we heard about the “mechanics” of receiving rTMS treatment but how, exactly, does flooding the brain with a magnetic field change the way we think?
Curieux de découvrir des recherches qui étudient le cerveau ? Curieux d’entendre les réflexions et questions de personnes concernées par des troubles
In this opening episode, after a spin through the funding landscape, PI Sean reveals the groundbreaking impetus behind the GLAD project – PLEX POWERED RESEARCH…
Having already established that the PLEX – Research Partners won’t be the ones having their brains “zapped”, who exactly will be included in the upcoming clinical trial and how do they qualify?
In French, with English subtitles, the discussions address psychotherapy and the effect it has on our emotions and our brains…
Gizmos on the head and machines that go “beep”? Before the team begin to define their roles in the research project, everyone needs to know what rTMS is all about…
